• News

Growth Hormone Improves Social Impairments From Autism Linked Disorder

  • (February 20, 2015)

New research has found that a growth hormone can significantly improve the social impairment associated with autism spectrum disorder (ASD) in patients with a related genetic syndrome. The pilot study, conducted at the Icahn School of Medicine at Mount Sinai, focused on the use of insulin-like growth factor-1 (IGF-1) to treat Phelan-McDermid syndrome (PMS), a disorder caused by a deletion or mutation of the SHANK3 gene on chromosome 22. “Ours is the first controlled trial of any treatment for Phelan-McDermid syndrome,” said Alexander Kolevzon, MD, clinical director of the Seaver Autism Center at the Icahn School of Medicine at Mount Sinai.

- Dr. Alexander Kolevzon, Associate Professor, Psychiatry, Pediatrics, Clinical Director, the Seaver Autism Center at the Icahn School of Medicine at Mount Sinai

Learn more 

Additional Coverage:
Business Standard 
News-Medical 
Medical Xpress 
Zee News 

Related Articles
Building exterior
Building exterior
Team
Building exterior
Inpatient Rehabiliation
ED Transformation
Winship Program Ribbon Cutting
masked doctor and nurse
New York skyscraper seen from a park
Lazarus Center
Own the Bone